[1] Dumitriu D, Dudea SM, Botar-Jid C, et al.Ultrasonographic and sonoelastographic features of pleomorphic adenomas of the salivary glands[J]. Med Ultrason, 2010, 12(3): 175-183. [2] Kawata R, Yoshimura K, Lee K, et al.Basal cell adenoma of the parotid gland: a clinicopathological study of nine cases-basal cell adenoma versus pleomorphic adenoma and Warthin's tumor[J]. Eur Arch Otorhinolaryngol, 2010, 267(5): 779-783. [3] 胡冬梅, 何雨, 郑娟娟, 等. 腮腺腺淋巴瘤的超声表现分析[J]. 临床超声医学杂志, 2016, 18(11): 787-788. [4] Burke CJ, Thomas RH, Howlett D.Imaging the major salivary glands[J]. Br J Oral Maxillofac Surg, 2011, 49(4): 261-269. [5] Zhang D, Wei Q, Wu GG, et al.Preoperative prediction of microvascular invasion in patients with hepatocellular carcinoma based on radiomics nomogram using contrast-enhanced ultrasound[J]. Front Oncol, 2021, 11: 709339. [6] Vicic E, Kojc N, Hovelja T, et al.Quantitative contrast-enhanced ultrasound for the differentiation of kidney allografts with significant histopathological injury[J]. Microcirculation, 2021, 28(8): e12732-e12732. [7] Griffon J, Buffello D, Gironn A, et al.Non-invasive ultrasonic description of tumor evolution[J]. Cancers, 2021, 13(18): 4560-4572. [8] Marschner CA, Geyer T, Froelich MF, et al.Diagnostic value of contrast-enhanced ultrasound for evaluation of transjugular intrahepatic portosystemic shunt perfusion[J]. Diagnostics (Basel), 2021, 11(9): 1593-1593. [9] Yang G, Ruan L.Imaging findings of prostate tuberculosis by transrectal contrast-enhanced ultrasound and comparison with 2D ultrasound and pathology[J]. Br J Radiol, 2021, 29: 20210713. [10] Brennan PA, Herd MK, Howlett DC, et al.Is ultrasound alone sufficient for imaging superficial lobe benign parotid tumours before surgery?[J]. Br J Oral Maxillofac Surg, 2012, 50(4): 333-337. [11] David E, Cantisani V, De Vincentiis M, et al.Contrast-enhanced ultrasound in the evaluation of parotid gland lesions: an update of the literature[J]. Ultrasound, 2016, 24(2): 104-110. [12] Leinonen MR, Raekallio MR, Vainio OM, et al.The effect of the sample size and location on contrast ultrasound measurement of perfusion parameters[J]. Vet Radiol Ultrasound, 2011, 52(1): 82-87. [13] Badea AF, Bran S, Tamas-Szora A, et al.Solid parotid tumors: an individual and integrative analysis of various ultrasonographic criteria. A prospective and observational study[J]. Med Ultrason, 2013, 15(4): 289-298. [14] Bozzato A, Zenk J, Greess H, et al.Potential of ultrasound diagnosis for parotid tumors: analysis of qualitative and quantitative parameters[J]. Otolaryngol Head Neck Surg, 2007, 137(4): 642-646. [15] Yan M, Xu D, Chen L, et al.Comparative study of qualitative and quantitative analyses of contrast-enhanced ultrasound and the diagnostic value of B-mode and color doppler for common benign tumors in the parotid gland[J]. Front Oncol, 2021, 11: 669542. [16] 蒋丽萍,周爱云,王婧玲.涎腺混合瘤和Warthin瘤的超声造影对比[J].中华医学超声杂志(电子版), 2018, 15(7): 502-505. [17] 张丽华,陈圣,陈玮吉,等. 超声造影对腮腺多形性腺瘤与腺淋巴瘤的鉴别诊断价值[J]. 中华实用诊断与治疗杂志, 2021, 35(1): 77-79. [18] 戴俊臣, 陈琴, 吴昊, 等. 涎腺多形性腺瘤常规超声及超声造影检查特征分析[J]. 中国超声医学杂志, 2015, 31(9): 769-771. [19] 张芳芳, 王宏桥, 贾暮云, 等. 超声造影在鉴别腮腺多形性腺瘤病理分型中的价值[J]. 中国医学影像学杂志, 2020, 28(8): 571-574. [20] Klotz LV, Ingrisch M, Eichhorn ME, et al.Monitoring parotid gland tumors with a new perfusion software for contrast-enhanced ultrasound[J]. Clin Hemorheol Microcirc, 2014, 58(1): 261-269. [21] Klotz LV, Gürkov R, Eichhorn ME, et al.Perfusion characteristics of parotid gland tumors evaluated by contrast-enhanced ultrasound[J]. Eur J Radiol, 2013, 82(12): 2227-2232. [22] 张青萍,周翔,柳建华. 新型超声造影剂对组织器官血流灌注的研究[J]. 放射学实践,2000,15(3): 170-172. [23] 杨琛,彭婵娟. 超声造影定量评价体系及其影响因素分析[J]. 中国肿瘤, 2016, 25(3): 212-218. |